Advanced Basal Cell Carcinoma clinical trials

Explore recruiting advanced basal cell carcinoma clinical trials.

Recruiting advanced basal cell carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Basal Cell Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase II, open-label study improving compliance and time of treatment after obtaining complete response through a tailored schedule of sonidegib in locally advanced basal cell carcinomas (BCC) – the SONIBEC trial

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2 study of intratumoral administration of L19IL2/L19TNF in locally advanced Basal Cell Carcinoma patients progressed on or intolerant to systemic treatment.

Germany, Italy, Greece, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2 controlled randomized study of the efficacy of L19IL2 or L19TNF or L19IL2/L19TNF intralesional injections for the treatment of locally advanced basal cell carcinoma patients.

Greece, Italy, Germany, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicenter, Randomized, Double blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Patidegib Gel 2% for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects with Gorlin Syndrome

Netherlands, France, Italy, Spain, Poland, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Evaluation of efficacy and safety of Cemiplimab as first line treatment for advanced basal cell carcinoma (CEMI-first) - An open label, single arm, prospective phase II trial of the DeCOG network

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase 2, open label study to evaluate safety and clinical activity of balstilimab in monotherapy in patients with advanced/metastatic non-melanoma skin cancers (AGENONMELA).

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Advanced Basal Cell Carcinoma trials by city

Advanced Basal Cell Carcinoma in Toronto Advanced Basal Cell Carcinoma in Vancouver Advanced Basal Cell Carcinoma in Montreal Advanced Basal Cell Carcinoma in Calgary Advanced Basal Cell Carcinoma in Edmonton Advanced Basal Cell Carcinoma in Ottawa Advanced Basal Cell Carcinoma in Winnipeg Advanced Basal Cell Carcinoma in Quebec City Advanced Basal Cell Carcinoma in Hamilton Advanced Basal Cell Carcinoma in Kitchener Advanced Basal Cell Carcinoma in London Advanced Basal Cell Carcinoma in Halifax Advanced Basal Cell Carcinoma in New York Advanced Basal Cell Carcinoma in Los Angeles Advanced Basal Cell Carcinoma in Chicago Advanced Basal Cell Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease